Picture of Etropal A.D. logo

ETR Etropal A.D. Income Statement

0.000.00%
bg flag iconLast trade - 00:00
HealthcareBalancedMicro CapSucker Stock

Annual income statement for Etropal A.D., fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
fx
Final
fx
Final
fx
Final
Revenue
Total Revenue5.993.455.738.0910.3
Cost of Revenue
Gross Profit0.5581.31.822.192.68
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses7.743.715.637.9210.1
Operating Profit-1.75-0.2610.10.1710.251
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1.77-0.4-0.0660.0230.102
Provision for Income Taxes
Net Income After Taxes-1.75-0.414-0.0630.0220.101
Minority Interest
Net Income Before Extraordinary Items
Net Income-1.76-0.367-0.0140.0460.155
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.76-0.367-0.0140.0460.155
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.352-0.073-0.0030.0090.031
Dividends per Share